Anesthetic-Induced Neurotoxicity: Molecular Pathways and Genetic Risk Factors
麻醉引起的神经毒性:分子途径和遗传风险因素
基本信息
- 批准号:10549751
- 负责人:
- 金额:$ 34.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAcuteAffectAgeAgingAllelesAmericanAnesthesia proceduresAnestheticsAnimal ModelAnimalsAwarenessBehavioralBiologicalCaringChildClinical ResearchClinical TrialsCognitiveCollectionCommunitiesDataDeliriumDiagnosticDrosophila genusDrosophila melanogasterElderlyElectron TransportEnvironmental Risk FactorExposure toFoundationsFunctional disorderGene ExpressionGeneral PopulationGeneral anesthetic drugsGenerationsGenesGeneticGenetic MarkersGenetic PolymorphismGenetic Predisposition to DiseaseGenetic ScreeningGoalsHeritabilityHeterozygoteHigh PrevalenceHourHumanHyperoxiaHypersensitivityImpaired cognitionIndividualIsofluraneLeigh DiseaseMeasuresMediatingMedicineMetabolicMetabolic PathwayMitochondriaMitochondrial DiseasesMitochondrial Electron Transport Complex IModelingMolecularMutationNerve DegenerationNervous SystemNeurodegenerative DisordersNeurogliaNeuronsNuclearNucleotidesOperative Surgical ProceduresOrthologous GeneOutcome StudyOxygenPathway interactionsPatientsPenetrancePerioperativePersonsPharmacogenomicsPhenotypePlayPopulationPredispositionPregnant WomenPreventionPreventivePublic HealthQuantitative Reverse Transcriptase PCRReportingResearchRiskRisk AssessmentRisk FactorsRoleShapesSocietiesSystemTestingTherapeuticTherapeutic InterventionToxic effectVolatilizationagedaging brainbrain healthclinically relevantdisease-causing mutationexperienceflygenetic approachgenetic manipulationgenetic risk factorgenome wide association studyhigh throughput screeningmiddle agemitochondrial dysfunctionmodel organismmortalitymutantneurotoxicitypersonalized medicinepre-clinicalprophylacticresponsesevofluranetranscriptome sequencing
项目摘要
Some individuals undergoing anesthesia and surgery will experience anesthetic-induced neurotoxicity (AiN)
attributable to volatile general anesthetic agents (VGAs). AiN after exposure to VGAs can present with different
phenotypes, including acute neurodegeneration, delirium, lifelong cognitive impairment in children and
accelerated or even de novo neurodegeneration in the aged. Despite controversial clinical trials, the FDA, in
a far-reaching response to recent data, has issued a warning on the use of VGAs in pregnant women and
young children. Furthermore, the American Society of Anesthesiologists' Perioperative Brain Health Initiative
has raised awareness of AiN for the aged brain. As neither the pathophysiology of AiN nor its risk factors are
understood, there are neither prophylactic nor therapeutic measures.
Our underlying hypothesis is that heritable factors determine the threshold for AiN vulnerability while biological
and environmental variables shape its phenotype. We propose to approach AiN with a pharmacogenomic
strategy in the fruit fly Drosophila melanogaster. We will use the ND2360114 strain, which is a model of Leigh
syndrome (a human neurodegenerative disease caused by mutation of NDUFS8, the mammalian ortholog of
ND23). Exposure of ND2360114 flies to VGAs results in four striking phenotypes: (1) young flies are equally
hypersensitive to the behavioral effects of isoflurane and sevoflurane (reproducing the human phenotype), (2)
middle-aged flies incur significant mortality within 24 hours after waking up from isoflurane, (3) genetic and
environmental manipulations profoundly modulate mortality, and (4) phenotypically normal ND2360114/+ flies
become sensitized to AiN from isoflurane at an advanced age thereby. We will use ND2360114 flies as a
sensitized model of AiN with rapid, unambiguous readout. To investigate the modulatory role of genetic
background on AiN, we will use genome-wide association study (GWAS) analysis to identify nucleotide
polymorphisms that modify AiN in ND2360114/+ flies. To determine the scope of heterozygous mutations that
increase the risk of AiN, we will screen candidate mutants in mitochondrial metabolic pathways. To identify
key metabolic regulators of AiN, we will use RNA-seq under experimental conditions that result in different
mortality rates.
These studies are significant because exposure to VGA affects millions of people of all ages every year and
concerns of AiN are widespread. Complications from exposure to anesthesia and surgery have long-lasting
consequences. Considering genetic background when assessing the individual risk of AiN is a step towards
personalized medicine. Understanding its pathophysiology offers a path to informed prevention and treatment.
一些接受麻醉和手术的个体会经历麻醉诱导的神经毒性(AIN)
可归因于挥发性全身麻醉剂(VGA)。暴露于VGA后的AIN可以呈现不同的
表型,包括急性神经变性、谵妄、儿童终身认知障碍和
加速甚至是新生的老年神经退行性变。尽管有争议的临床试验,FDA,在
对最近的数据做出了深远的回应,对孕妇使用VGA发出了警告,
年幼的孩子。此外,美国麻醉医师协会的围手术期脑健康倡议,
提高了老年人对AIN的认识。由于AIN的病理生理学及其危险因素都不是
据了解,既没有预防措施,也没有治疗措施。
我们的基本假设是,遗传因素决定了AIN脆弱性的阈值,而生物学因素决定了AIN脆弱性的阈值。
环境变量塑造了它的表型。我们建议用药物基因组学方法接近AIN。
果蝇的策略。我们将使用ND 2360114菌株,这是Leigh的模型
综合征(由NDUFS 8突变引起的人类神经退行性疾病,NDUFS 8是哺乳动物的直系同源物,
ND 23)。ND 2360114果蝇暴露于VGAs导致四种显著的表型:(1)幼蝇与对照组相比,
对异氟烷和七氟烷的行为效应过敏(再现人类表型),(2)
中年果蝇在异氟烷苏醒后24小时内发生显著死亡,(3)遗传和
环境操作深刻调节死亡率,和(4)表型正常ND 2360114/+苍蝇
从而在高龄时对异氟烷中的AiN变得敏感。我们将使用ND 2360114苍蝇作为
AiN的敏化模型,具有快速,明确的读数。探讨遗传因素对细胞凋亡的调节作用,
在AiN的背景下,我们将使用全基因组关联研究(GWAS)分析来识别核苷酸
在ND 2360114/+果蝇中修饰AiN的多态性。为了确定杂合突变的范围,
增加AIN的风险,我们将筛选线粒体代谢途径的候选突变体。以识别
AiN的关键代谢调节因子,我们将在实验条件下使用RNA-seq,
死亡率。
这些研究意义重大,因为暴露于VGA每年影响数百万所有年龄段的人,
对AI的担忧非常普遍。暴露于麻醉和手术的并发症具有长期的
后果在评估AIN的个体风险时考虑遗传背景是迈向
个性化医疗了解其病理生理学提供了一条知情的预防和治疗的途径。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Serial Anesthesia Array for the High-Throughput Investigation of Volatile Agents Using Drosophila melanogaster.
- DOI:10.3791/65144
- 发表时间:2023-02-24
- 期刊:
- 影响因子:0
- 作者:Olufs ZPG;Johnson-Schlitz D;Wassarman DA;Perouansky M
- 通讯作者:Perouansky M
Mutations in Complex I of the Mitochondrial Electron-Transport Chain Sensitize the Fruit Fly (Drosophila melanogaster) to Ether and Non-Ether Volatile Anesthetics.
- DOI:10.3390/ijms24031843
- 发表时间:2023-01-17
- 期刊:
- 影响因子:5.6
- 作者:Borchardt, Luke A. A.;Scharenbrock, Amanda R. R.;Olufs, Zachariah P. G.;Wassarman, David A. A.;Perouansky, Misha
- 通讯作者:Perouansky, Misha
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID WASSARMAN其他文献
DAVID WASSARMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID WASSARMAN', 18)}}的其他基金
Genetic Analysis of Neurodegeneration in Drosophila
果蝇神经变性的遗传分析
- 批准号:
9018070 - 财政年份:2014
- 资助金额:
$ 34.99万 - 项目类别:
Genetic Analysis of Neurodegeneration in Drosophila
果蝇神经变性的遗传分析
- 批准号:
9223746 - 财政年份:2014
- 资助金额:
$ 34.99万 - 项目类别:
Genetic Analysis of Neurodegeneration in Drosophila
果蝇神经变性的遗传分析
- 批准号:
8688528 - 财政年份:2014
- 资助金额:
$ 34.99万 - 项目类别:
Genetic Analysis of Neurodegeneration in Drosophila
果蝇神经变性的遗传分析
- 批准号:
8814288 - 财政年份:2014
- 资助金额:
$ 34.99万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 34.99万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 34.99万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 34.99万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 34.99万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 34.99万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 34.99万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 34.99万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 34.99万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 34.99万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 34.99万 - 项目类别:
Operating Grants














{{item.name}}会员




